Antibody-conjugated pH-sensitive liposomes for HER-2 positive breast cancer: development, characterization, <i>in vitro</i> and <i>in vivo</i> assessment-Reference-Cited by-同舟云学术

Antibody-conjugated pH-sensitive liposomes for HER-2 positive breast cancer: development, characterization, in vitro and in vivo assessment

Published:2023-08-28 Issue: Volume: Page:1-25
ISSN:0898-2104
Container-title:Journal of Liposome Research
language:en
Short-container-title:Journal of Liposome Research

Author:

Raikwar Sarjana¹,Yadav Vivek²,Jain Sanyog²,Jain Sanjay K.¹

Affiliation:

1. Pharmaceutics Research Projects Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar (M.P.), India

2. Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/08982104.2023.2248505

Reference50 articles.

1. The neu oncogene encodes an epidermal growth factor receptor-related protein

2. Liposomes as nanomedical devices

3. New Global Survey Shows an Increasing Cancer Burden

4. Humanization of an anti-p185HER2 antibody for human cancer therapy.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating a targeted Palbociclib-Trastuzumab loaded smart niosome platform for treating HER2 positive breast cancer cells;International Journal of Pharmaceutics: X;2024-06

2. Microneedle-mediated nanomedicine to enhance therapeutic and diagnostic efficacy;Nano Convergence;2024-04-18

3. Introduction to liposome assisted drug delivery;Liposomes in Drug Delivery;2024